Author Archives: StopSmoking

Johnny Depp CBD Gummies Reviews – Johnny Depp CBD Gummies , Quit Smoking and 100 percent Pain Relief! Job – (DONOTUSE) University of California Santa Barbara Police Department

[ad_1] Corporate(DONOTUSE) University of California Santa Barbara Police Department – Santa Barbara, California Contact Information Johnny Depp CBD Gummies Johnny Depp CBD Gummies (DONOTUSE) University of California Santa Barbara Police Department Public Safety 574, Mesa Rd, Goleta, CA Santa Barbara, California 93117 phone: Johnny Depp CBD Gummies [ad_2] Source link

Read more

These stroke tips from Pueblo’s Parkview Medical Center could save lives

A stroke victim undergoes rehabilitation with a physical therapist. May is National Stroke Awareness Month in the U.S.

[ad_1] Someone in the United States suffers a stroke roughly every 40 seconds, Parkview Medical Center in Pueblo has said as the United States marks National Stroke Awareness Month in May.  Parkview last year cared for 469 patients who had an ischemic stroke, caused by a blocked artery; hemorrhagic stroke, caused by a leaking blood vessel, or a transient ischemic attack, often called a TIA or mini-stroke, in which a person has symptoms like those of a stroke, lasting only a few minutes. Throughout the month of May, the […]

Read more

Florida man Seth Settle arrested for killing mom who told him no smoking in room

[ad_1] A 19-year-old Florida man was arrested and charged with allegedly shooting and killing his mother in their Polk County home this week. Seth Settle reportedly shot and killed his mother Thursday after she ordered him to stop smoking cigars in his bedroom, Polk County Sheriff Grady Judd said, according to Fox 13 Tampa Bay. The incident occurred shortly after Settle’s father left work on what seemed like a normal weekday. Shortly after 9:30 a.m., though, he had received a call that his wife had been taken to a hospital. Authorities were first alerted to […]

Read more

Quarterly Activities Report and Appendix 4C Cash Flow Statement

[ad_1] Highlights: Positive phase 2a clinical trial results for IHL-42X with 60% of trial participants experiencing at least a 55% reduction in the Apnoea Hypopnea Index (‘AHI’) 20% of IHL-42X clinical trial participants experienced a reduction in AHI of greater than 80% completes comprehensive in vivo study on the neuroprotective capability of IHL-216A with results being analysed to be released within 2-3 weeks treatment commences in the phase 2a clinical trial to assess psilocybin and specialised psychotherapy for the treatment of generalised anxiety disorder initiates a second […]

Read more
1 52 53 54 55 56 83